Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL
Summary The emergence of non‐Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed...
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2008-11, Vol.143 (3), p.387-394 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 394 |
|---|---|
| container_issue | 3 |
| container_start_page | 387 |
| container_title | British journal of haematology |
| container_volume | 143 |
| creator | Landmann, Eva Oschlies, Ilske Zimmermann, Martin Moser, Olga Graf, Norbert Suttorp, Meinolf Greiner, Jeannette Reiter, Alfred |
| description | Summary
The emergence of non‐Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed the data of patients reported to the NHL‐Berlin‐Frankfurt‐Münster study centre from 1986 to 2005. Out of the total of 2968 NHL‐patients registered, 11 patients were assessed as having suffered from NHL as a proven SN. Four additional children had most likely suffered from NHL as an SN, but a late relapse of the first neoplasm could not be ruled out unequivocally. In the patients with proven SN, median age at diagnosis of the primary malignancy was 3·9 years (range 2–11·7). The median age at diagnosis of NHL was 7·6 years (range 4·7–18). Only lymphoblastic (n = 7) and diffuse large B‐cell (n = 4) lymphomas were diagnosed as SN. The estimated 5‐year event‐free survival from time of diagnosis of NHL was 91% [95% confidence interval (CI) 74–100%] in patients with proven SNs and 84% (95% CI 63–100%) when the patients with probable SNs were included in the analysis. We concluded that secondary NHL in children and adolescents confers a favourable prognosis. |
| doi_str_mv | 10.1111/j.1365-2141.2008.07356.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69751438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19322111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4786-676fc73e6b714127c32182375ecb8f13baebdf0ce759edd5091c66444fbafded3</originalsourceid><addsrcrecordid>eNqNkc9u1DAQxi0EokvhFZAvIDgk9Z_Edg4coAK2aAUH4Gw59phkSewlzorujUfgGXkSnO6qHIsPtjXzm_H4-xDClJQ0r4ttSbmoC0YrWjJCVEkkr0V5fQ-tbhP30YoQIgtKKnWGHqW0JYRyUtOH6IwqyRpVsxXqPoONwZnpgEMMf379Xkf37Xsf8HAYd10cDX7xcb15iXPEdv3gJgjYBIeNiwMkC2FO2PgZpmO6i9Fha4LNgTh3eZ87E3Bu8Rg98GZI8OR0nqOv795-uVwXm0_vry5fbwpbSSUKIYW3koNoZf4Dk5YzqhiXNdhWecpbA63zxIKsG3CuJg21QlRV5VvjHTh-jp4f--6m-GMPadZjn-ccBhMg7pMWjaxpxdWdIG04Y1nsDKojaKeY0gRe76Z-zIppSvRih97qRXW9qK4XO_SNHfo6lz49vbFvR3D_Ck_6Z-DZCTDJmsFPWbo-3XKMSKl4QzL36sj97Ac4_PcA-s2H9XLjfwH1HKa1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19322111</pqid></control><display><type>article</type><title>Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Landmann, Eva ; Oschlies, Ilske ; Zimmermann, Martin ; Moser, Olga ; Graf, Norbert ; Suttorp, Meinolf ; Greiner, Jeannette ; Reiter, Alfred</creator><creatorcontrib>Landmann, Eva ; Oschlies, Ilske ; Zimmermann, Martin ; Moser, Olga ; Graf, Norbert ; Suttorp, Meinolf ; Greiner, Jeannette ; Reiter, Alfred ; Berlin-Frankfurt-Münster group ; on behalf of the Berlin‐Frankfurt‐Münster group</creatorcontrib><description>Summary
The emergence of non‐Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed the data of patients reported to the NHL‐Berlin‐Frankfurt‐Münster study centre from 1986 to 2005. Out of the total of 2968 NHL‐patients registered, 11 patients were assessed as having suffered from NHL as a proven SN. Four additional children had most likely suffered from NHL as an SN, but a late relapse of the first neoplasm could not be ruled out unequivocally. In the patients with proven SN, median age at diagnosis of the primary malignancy was 3·9 years (range 2–11·7). The median age at diagnosis of NHL was 7·6 years (range 4·7–18). Only lymphoblastic (n = 7) and diffuse large B‐cell (n = 4) lymphomas were diagnosed as SN. The estimated 5‐year event‐free survival from time of diagnosis of NHL was 91% [95% confidence interval (CI) 74–100%] in patients with proven SNs and 84% (95% CI 63–100%) when the patients with probable SNs were included in the analysis. We concluded that secondary NHL in children and adolescents confers a favourable prognosis.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2008.07356.x</identifier><identifier>PMID: 18729852</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Age Factors ; Biological and medical sciences ; Child ; Child, Preschool ; childhood cancer ; Disease-Free Survival ; Europe - epidemiology ; Female ; Hematologic and hematopoietic diseases ; Humans ; Infant ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, Non-Hodgkin - diagnosis ; Lymphoma, Non-Hodgkin - epidemiology ; Lymphoma, Non-Hodgkin - etiology ; Lymphoma, Non-Hodgkin - therapy ; Male ; Medical sciences ; Neoplasms, Second Primary - diagnosis ; Neoplasms, Second Primary - epidemiology ; Neoplasms, Second Primary - etiology ; Neoplasms, Second Primary - therapy ; non‐Hodgkin lymphoma ; Prognosis ; Retrospective Studies ; secondary malignancies ; secondary neoplasm</subject><ispartof>British journal of haematology, 2008-11, Vol.143 (3), p.387-394</ispartof><rights>2008 The Authors. Journal Compilation © 2008 Blackwell Publishing Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4786-676fc73e6b714127c32182375ecb8f13baebdf0ce759edd5091c66444fbafded3</citedby><cites>FETCH-LOGICAL-c4786-676fc73e6b714127c32182375ecb8f13baebdf0ce759edd5091c66444fbafded3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2008.07356.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2008.07356.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20778390$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18729852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Landmann, Eva</creatorcontrib><creatorcontrib>Oschlies, Ilske</creatorcontrib><creatorcontrib>Zimmermann, Martin</creatorcontrib><creatorcontrib>Moser, Olga</creatorcontrib><creatorcontrib>Graf, Norbert</creatorcontrib><creatorcontrib>Suttorp, Meinolf</creatorcontrib><creatorcontrib>Greiner, Jeannette</creatorcontrib><creatorcontrib>Reiter, Alfred</creatorcontrib><creatorcontrib>Berlin-Frankfurt-Münster group</creatorcontrib><creatorcontrib>on behalf of the Berlin‐Frankfurt‐Münster group</creatorcontrib><title>Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary
The emergence of non‐Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed the data of patients reported to the NHL‐Berlin‐Frankfurt‐Münster study centre from 1986 to 2005. Out of the total of 2968 NHL‐patients registered, 11 patients were assessed as having suffered from NHL as a proven SN. Four additional children had most likely suffered from NHL as an SN, but a late relapse of the first neoplasm could not be ruled out unequivocally. In the patients with proven SN, median age at diagnosis of the primary malignancy was 3·9 years (range 2–11·7). The median age at diagnosis of NHL was 7·6 years (range 4·7–18). Only lymphoblastic (n = 7) and diffuse large B‐cell (n = 4) lymphomas were diagnosed as SN. The estimated 5‐year event‐free survival from time of diagnosis of NHL was 91% [95% confidence interval (CI) 74–100%] in patients with proven SNs and 84% (95% CI 63–100%) when the patients with probable SNs were included in the analysis. We concluded that secondary NHL in children and adolescents confers a favourable prognosis.</description><subject>Adolescent</subject><subject>Age Factors</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>childhood cancer</subject><subject>Disease-Free Survival</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, Non-Hodgkin - diagnosis</subject><subject>Lymphoma, Non-Hodgkin - epidemiology</subject><subject>Lymphoma, Non-Hodgkin - etiology</subject><subject>Lymphoma, Non-Hodgkin - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neoplasms, Second Primary - diagnosis</subject><subject>Neoplasms, Second Primary - epidemiology</subject><subject>Neoplasms, Second Primary - etiology</subject><subject>Neoplasms, Second Primary - therapy</subject><subject>non‐Hodgkin lymphoma</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>secondary malignancies</subject><subject>secondary neoplasm</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9u1DAQxi0EokvhFZAvIDgk9Z_Edg4coAK2aAUH4Gw59phkSewlzorujUfgGXkSnO6qHIsPtjXzm_H4-xDClJQ0r4ttSbmoC0YrWjJCVEkkr0V5fQ-tbhP30YoQIgtKKnWGHqW0JYRyUtOH6IwqyRpVsxXqPoONwZnpgEMMf379Xkf37Xsf8HAYd10cDX7xcb15iXPEdv3gJgjYBIeNiwMkC2FO2PgZpmO6i9Fha4LNgTh3eZ87E3Bu8Rg98GZI8OR0nqOv795-uVwXm0_vry5fbwpbSSUKIYW3koNoZf4Dk5YzqhiXNdhWecpbA63zxIKsG3CuJg21QlRV5VvjHTh-jp4f--6m-GMPadZjn-ccBhMg7pMWjaxpxdWdIG04Y1nsDKojaKeY0gRe76Z-zIppSvRih97qRXW9qK4XO_SNHfo6lz49vbFvR3D_Ck_6Z-DZCTDJmsFPWbo-3XKMSKl4QzL36sj97Ac4_PcA-s2H9XLjfwH1HKa1</recordid><startdate>200811</startdate><enddate>200811</enddate><creator>Landmann, Eva</creator><creator>Oschlies, Ilske</creator><creator>Zimmermann, Martin</creator><creator>Moser, Olga</creator><creator>Graf, Norbert</creator><creator>Suttorp, Meinolf</creator><creator>Greiner, Jeannette</creator><creator>Reiter, Alfred</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200811</creationdate><title>Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL</title><author>Landmann, Eva ; Oschlies, Ilske ; Zimmermann, Martin ; Moser, Olga ; Graf, Norbert ; Suttorp, Meinolf ; Greiner, Jeannette ; Reiter, Alfred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4786-676fc73e6b714127c32182375ecb8f13baebdf0ce759edd5091c66444fbafded3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Age Factors</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>childhood cancer</topic><topic>Disease-Free Survival</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, Non-Hodgkin - diagnosis</topic><topic>Lymphoma, Non-Hodgkin - epidemiology</topic><topic>Lymphoma, Non-Hodgkin - etiology</topic><topic>Lymphoma, Non-Hodgkin - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neoplasms, Second Primary - diagnosis</topic><topic>Neoplasms, Second Primary - epidemiology</topic><topic>Neoplasms, Second Primary - etiology</topic><topic>Neoplasms, Second Primary - therapy</topic><topic>non‐Hodgkin lymphoma</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>secondary malignancies</topic><topic>secondary neoplasm</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Landmann, Eva</creatorcontrib><creatorcontrib>Oschlies, Ilske</creatorcontrib><creatorcontrib>Zimmermann, Martin</creatorcontrib><creatorcontrib>Moser, Olga</creatorcontrib><creatorcontrib>Graf, Norbert</creatorcontrib><creatorcontrib>Suttorp, Meinolf</creatorcontrib><creatorcontrib>Greiner, Jeannette</creatorcontrib><creatorcontrib>Reiter, Alfred</creatorcontrib><creatorcontrib>Berlin-Frankfurt-Münster group</creatorcontrib><creatorcontrib>on behalf of the Berlin‐Frankfurt‐Münster group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Landmann, Eva</au><au>Oschlies, Ilske</au><au>Zimmermann, Martin</au><au>Moser, Olga</au><au>Graf, Norbert</au><au>Suttorp, Meinolf</au><au>Greiner, Jeannette</au><au>Reiter, Alfred</au><aucorp>Berlin-Frankfurt-Münster group</aucorp><aucorp>on behalf of the Berlin‐Frankfurt‐Münster group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2008-11</date><risdate>2008</risdate><volume>143</volume><issue>3</issue><spage>387</spage><epage>394</epage><pages>387-394</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary
The emergence of non‐Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed the data of patients reported to the NHL‐Berlin‐Frankfurt‐Münster study centre from 1986 to 2005. Out of the total of 2968 NHL‐patients registered, 11 patients were assessed as having suffered from NHL as a proven SN. Four additional children had most likely suffered from NHL as an SN, but a late relapse of the first neoplasm could not be ruled out unequivocally. In the patients with proven SN, median age at diagnosis of the primary malignancy was 3·9 years (range 2–11·7). The median age at diagnosis of NHL was 7·6 years (range 4·7–18). Only lymphoblastic (n = 7) and diffuse large B‐cell (n = 4) lymphomas were diagnosed as SN. The estimated 5‐year event‐free survival from time of diagnosis of NHL was 91% [95% confidence interval (CI) 74–100%] in patients with proven SNs and 84% (95% CI 63–100%) when the patients with probable SNs were included in the analysis. We concluded that secondary NHL in children and adolescents confers a favourable prognosis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18729852</pmid><doi>10.1111/j.1365-2141.2008.07356.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2008-11, Vol.143 (3), p.387-394 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69751438 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals |
| subjects | Adolescent Age Factors Biological and medical sciences Child Child, Preschool childhood cancer Disease-Free Survival Europe - epidemiology Female Hematologic and hematopoietic diseases Humans Infant Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, Non-Hodgkin - diagnosis Lymphoma, Non-Hodgkin - epidemiology Lymphoma, Non-Hodgkin - etiology Lymphoma, Non-Hodgkin - therapy Male Medical sciences Neoplasms, Second Primary - diagnosis Neoplasms, Second Primary - epidemiology Neoplasms, Second Primary - etiology Neoplasms, Second Primary - therapy non‐Hodgkin lymphoma Prognosis Retrospective Studies secondary malignancies secondary neoplasm |
| title | Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A56%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secondary%20non%E2%80%90Hodgkin%20lymphoma%20(NHL)%20in%20children%20and%20adolescents%20after%20childhood%20cancer%20other%20than%20NHL&rft.jtitle=British%20journal%20of%20haematology&rft.au=Landmann,%20Eva&rft.aucorp=Berlin-Frankfurt-M%C3%BCnster%20group&rft.date=2008-11&rft.volume=143&rft.issue=3&rft.spage=387&rft.epage=394&rft.pages=387-394&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.2008.07356.x&rft_dat=%3Cproquest_cross%3E19322111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19322111&rft_id=info:pmid/18729852&rfr_iscdi=true |